Personalis provides researchers, clinicians and pharmaceutical companies with highly accurate sequencing and interpretation of human exomes and genomes. The company is based on proprietary technology originally developed at Stanford University. CEO, John West, was formerly CEO of the next-generationsequencing (NGS) company, Solexa (a former Abingworth portfolio company), which was acquired by Illumina in 2007 and became the basis for Illumina’s NGS product line.

Location Menlo Park, California
CEO John West
Partner Vincent Miles
Website www.personalis.com